HCP INFORMATION Bayer Logo Bayer Logo Bayer Logo

ReFineDR

Observational study

Observational study to investigate finerenone for the prevention of diabetic retinopathy

Finerenone is also being investigated for the prevention of diabetic retinopathy in patients with chronic kidney disease and type 2 diabetes (ReFineDR study; N=~800)10

Alt tag

ReFineDR study objective and patient population

© 2020 Bayer AG

This website is intended to provide information to an international audience outside the USA and UK

Last update: 18/09/2020